FMR LLC bought 116,000 shares of CONSUN PHARMA on the SEHK open market at an average of HKD 14.4242 per share on September 24, 2026, involving about HKD 1.67 million. This is an on-exchange active trade, i.e. a direct dealing in the secondary market.
Prior to the acquisition, FMR LLC's long position in CONSUN PHARMA was 75.66 million shares, representing 8.99%; following the acquisition, the holding changed to 75.77 million shares, with the long position ratio rising to 9.0%.